JP2005514406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514406A5 JP2005514406A5 JP2003557275A JP2003557275A JP2005514406A5 JP 2005514406 A5 JP2005514406 A5 JP 2005514406A5 JP 2003557275 A JP2003557275 A JP 2003557275A JP 2003557275 A JP2003557275 A JP 2003557275A JP 2005514406 A5 JP2005514406 A5 JP 2005514406A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- nitric oxide
- oxide donor
- stem cells
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34547802P | 2002-01-04 | 2002-01-04 | |
| PCT/US2003/000323 WO2003056899A2 (en) | 2002-01-04 | 2003-01-06 | Nitric oxide donors for treatment of disease and injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009181759A Division JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005514406A JP2005514406A (ja) | 2005-05-19 |
| JP2005514406A5 true JP2005514406A5 (https=) | 2009-09-24 |
| JP4545440B2 JP4545440B2 (ja) | 2010-09-15 |
Family
ID=23355218
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003557275A Expired - Fee Related JP4545440B2 (ja) | 2002-01-04 | 2003-01-06 | 疾患および損傷の処置のための一酸化窒素ドナー |
| JP2009181759A Pending JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009181759A Pending JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050143388A1 (https=) |
| EP (1) | EP1469852A4 (https=) |
| JP (2) | JP4545440B2 (https=) |
| CN (1) | CN1638775A (https=) |
| AU (1) | AU2003210447B2 (https=) |
| CA (1) | CA2471147C (https=) |
| IL (1) | IL162850A0 (https=) |
| WO (1) | WO2003056899A2 (https=) |
| ZA (1) | ZA200405507B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007010337A2 (de) * | 2005-07-15 | 2007-01-25 | Proxomed Medizintechnik Gmbh | Verwendung von phosphodiesterase typ 5-hemmern für die prävention und behandlung von adipositas, sowie abgabesysteme für dieselben |
| CA2629463A1 (en) * | 2005-11-14 | 2008-02-21 | Scott A. Small | Imaging correlates of neurogenesis with mri |
| US8841300B2 (en) | 2006-10-02 | 2014-09-23 | Jerry M. Held | Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
| CN101754756A (zh) * | 2007-05-18 | 2010-06-23 | 维瓦斯公司 | 包含磷酸二酯酶-5抑制剂的新组合和它们的用途 |
| WO2009046377A2 (en) * | 2007-10-04 | 2009-04-09 | Medistem Laboratories, Inc. | Compositions and methods of stem cell therapy for autism |
| US20100316622A1 (en) * | 2007-11-02 | 2010-12-16 | University Of Miami | Diagnosis and treatment of cardiac disorders |
| NZ631258A (en) | 2012-04-25 | 2016-11-25 | Takeda Pharmaceuticals Co | Nitrogenated heterocyclic compound |
| WO2014010732A1 (ja) | 2012-07-13 | 2014-01-16 | 武田薬品工業株式会社 | 複素環化合物 |
| ES2635016T3 (es) * | 2013-03-01 | 2017-10-02 | Fundación Para La Investigación Médica Aplicada | Nuevos compuestos como inhibidores duales de fosfodiesterasas e histonas deacetilasas |
| EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP6427491B2 (ja) | 2013-07-03 | 2018-11-21 | 武田薬品工業株式会社 | 複素環化合物 |
| EP3018123B1 (en) | 2013-07-03 | 2023-05-10 | Takeda Pharmaceutical Company Limited | Amide compound |
| US10297661B2 (en) * | 2017-06-30 | 2019-05-21 | Taiwan Semiconductor Manufacturing Co., Ltd. | High voltage resistor device |
| JP7770572B2 (ja) * | 2021-12-14 | 2025-11-14 | チェンアオ ジンインファ ファーマシューティカル | 虚血性脳損傷を予防または治療するための医薬の調製におけるアイルデナフィルまたはその塩の使用 |
| TWI879058B (zh) * | 2023-08-31 | 2025-04-01 | 未來新藥股份有限公司 | Pde5抑制劑組合於促進神經突生長之新穎用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2224195A (en) * | 1994-04-15 | 1995-11-10 | Masaomi Iyo | Medicinal composition for treating tardive dyskinesia and utilization thereof |
| US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US6043224A (en) * | 1996-09-05 | 2000-03-28 | The Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| US6043223A (en) * | 1997-11-12 | 2000-03-28 | The Regents Of The University Of California | Enhanced opening of abnormal brain tissue capillaries |
| DE19834507A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil |
| ES2531592T3 (es) * | 1999-05-14 | 2015-03-17 | Henry Ford Health System | Trasplante de médula ósea para el tratamiento de la apoplejía |
| EP1233670B1 (en) * | 1999-06-14 | 2008-09-17 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
| US6075028A (en) * | 1999-09-23 | 2000-06-13 | Graham; Richard | Method of treating Tourette's syndrome and related CNS disorders |
| IL139073A0 (en) * | 1999-10-21 | 2001-11-25 | Pfizer | Treatment of neuropathy |
| US6271228B1 (en) | 2000-04-28 | 2001-08-07 | Pfizer Inc. | Blood pressure stabilization during hemodialysis |
| EP2316531A1 (en) * | 2000-08-10 | 2011-05-04 | Cold Spring Harbor Laboratory | Augmented cognitive training |
-
2003
- 2003-01-06 EP EP03729347A patent/EP1469852A4/en not_active Withdrawn
- 2003-01-06 CN CNA038048817A patent/CN1638775A/zh active Pending
- 2003-01-06 IL IL16285003A patent/IL162850A0/xx unknown
- 2003-01-06 AU AU2003210447A patent/AU2003210447B2/en not_active Ceased
- 2003-01-06 JP JP2003557275A patent/JP4545440B2/ja not_active Expired - Fee Related
- 2003-01-06 CA CA2471147A patent/CA2471147C/en not_active Expired - Fee Related
- 2003-01-06 WO PCT/US2003/000323 patent/WO2003056899A2/en not_active Ceased
- 2003-01-06 US US10/500,694 patent/US20050143388A1/en not_active Abandoned
-
2004
- 2004-07-12 ZA ZA2004/05507A patent/ZA200405507B/en unknown
-
2009
- 2009-08-04 JP JP2009181759A patent/JP2009256374A/ja active Pending
-
2010
- 2010-09-24 US US12/889,873 patent/US20120009152A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005514406A5 (https=) | ||
| Schwartz et al. | Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity | |
| DE60336934D1 (de) | Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten | |
| CN107137700B (zh) | 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用 | |
| JP2022526820A (ja) | 間葉系幹細胞およびそのエクソソームによる微小血管障害の治療 | |
| Colombo et al. | Modeling hypoxia induced factors to treat pulpal inflammation and drive regeneration | |
| Wang et al. | Valproic acid labeled chitosan nanoparticles promote the proliferation and differentiation of neural stem cells after spinal cord injury | |
| JP2019142831A5 (https=) | ||
| EP2330111A3 (en) | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | |
| WO2022076556A3 (en) | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 | |
| Shirzad et al. | Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine | |
| Xian et al. | Exosomes from adipose-derived stem cells can prevent medication-related osteonecrosis of the jaw | |
| García-Ayuso et al. | Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations | |
| Tan et al. | Biomaterial‐Facilitated Local Delivery of Stem Cell‐Derived Small Extracellular Vesicles: Perspectives in Surgical Therapy | |
| Jo et al. | Physiological change of striatum and ventral midbrain's glia cell in response to different exercise modalities | |
| JP5334584B2 (ja) | アミノ酸とヒアルロン酸ナトリウムを基にした滅菌粉末の形態の創傷治癒医薬組成物 | |
| Fu et al. | New hope for esophageal stricture prevention: A prospective single-center trial on acellular dermal matrix | |
| Ara et al. | Effect of various treatment modalities after spinal cord injury | |
| CN1258371C (zh) | 包括大根草有机提取物的组合物及其应用 | |
| CN111920827B (zh) | 促组织愈合的复方缓释纳米粒的制备方法 | |
| Nasrat et al. | Role of blood-let out cupping therapy in angina and angina risk management | |
| Soria et al. | Treatment of pyoderma gangrenosum with cyclosporin A | |
| CN107073077B (zh) | 睫状神经营养因子鼻腔给药系统及其制备方法和应用 | |
| Keagle et al. | Bioregenerative Applications of the Human Mesenchymal Stem Cell-Derived Secretome: Part-I | |
| CN120118968A (zh) | 具有缓解肌少症作用鹿肉肽的制备方法及其缓解肌少症作用的验证方法 |